CA1182143A - Antimicrobial ultraviolet irradiation of connector for continuous ambulatory peritoneal dialysis - Google Patents

Antimicrobial ultraviolet irradiation of connector for continuous ambulatory peritoneal dialysis

Info

Publication number
CA1182143A
CA1182143A CA000400135A CA400135A CA1182143A CA 1182143 A CA1182143 A CA 1182143A CA 000400135 A CA000400135 A CA 000400135A CA 400135 A CA400135 A CA 400135A CA 1182143 A CA1182143 A CA 1182143A
Authority
CA
Canada
Prior art keywords
connector
ultraviolet
ultraviolet light
valve
peritoneal dialysis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000400135A
Other languages
French (fr)
Inventor
Ralph Kulin
Jack W. Moncrief
Robert P. Popovich
Ronald C. Stauber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter Travenol Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Travenol Laboratories Inc filed Critical Baxter Travenol Laboratories Inc
Application granted granted Critical
Publication of CA1182143A publication Critical patent/CA1182143A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/10Tube connectors; Tube couplings
    • A61M39/16Tube connectors; Tube couplings having provision for disinfection or sterilisation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654Dialysates therefor
    • A61M1/1656Apparatus for preparing dialysates
    • A61M1/1674Apparatus for preparing dialysates using UV radiation sources for sterilising the dialysate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/285Catheters therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/10Tube connectors; Tube couplings
    • A61M2039/1083Tube connectors; Tube couplings having a plurality of female connectors, e.g. Luer connectors
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S604/00Surgery
    • Y10S604/905Aseptic connectors or couplings, e.g. frangible, piercable
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T137/00Fluid handling
    • Y10T137/8593Systems
    • Y10T137/86493Multi-way valve unit
    • Y10T137/86815Multiple inlet with single outlet
    • Y10T137/86823Rotary valve

Abstract

Abstract of the Disclosure A connector valve for selectively permitting the transfer of fluids therethrough is described. Multiple-way valve means communicates with a plurality of conduits and selectively permits and prevents flow between the con-duits. The multiple-way valve means comprises outer walls made of a substantially ultraviolet-transmissive material, with the outer walls of the multiple-way valve means pref-erably enclosing an elastomeric seal member defining rota-table channel means for communication with differing con-duits at differing rotational positions, and also provi-ding a rotatable seal against inner surfaces of the outer walls to maintain an antimicrobial seal of said conduits.
The channel means is exposed along its entire length to an inner surface of an outer wall, to facilitate the anti-microbial effect of ultraviolet radiation. Also, a novel method of practicing continuous ambulatory peritoneal dialysis, and an ultraviolet light applicator, is dis-closed.

Description

~Z~3 ANTIMICROBIAL ULTRAVIOLET IRRADIATION OF
CONNECTOR FOR CONTINUOUS AMBULATORY PERITONEAL DIALYSIS

Back~round of the Invention The recently developed technique of continuous ambu-latory peritoneal dialysis (CAPD) to remove impuritiesfrom the blood of a patient whose kidneys have failed permits the patient being dialyzed to carry a surgically implanted catheter which may be connected intermittently to a peritoneal dialysis transfer set. The transfer set, in turn, connects to a bag of peritoneal dialysis solu-tion, which is emptied through the transfer set into the peritoneal cavity (CAPD infusion phase). The patient is not "tied" to a machine and can be ambulatory while the dialysis across the peritoneal membrane (CAPD dwell phase) takes place. After the dwell phase, the peritoneal dialysis solution is drained (CAPD drain phase) ~rom the peritoneal cavity. This can be done by allowing the solu-tion to flow back into the bag; there is preferably no disconnection of the bag during the dwell phase. After the drain phase, the bag with spent peritoneal dialysis solution may be dis~onnected from the transfer set and discarded.
A description of the continuous ambulatory peritoneal dialysis technique may be found in Popovich et al. U.S.
Patent No. 4,239,041, issued December 16, 1980 and entitled "METHOD FOR CONTINUOUS AMBULATORY PERITONEAL
DIALYSIS".
It is important to make the connections and discon-nections of the bags of fresh and spent peritoneal dialysis solution in an aseptic manner, since patients undergoing peritoneal dialysis risk developing peri-tonitiq, an infection which is relatively difficult to control. The risk of bacterial or other microbial contamination of the peri oneal dialysis system is of course increased at the time when the connections and disconnections of the solution containers to the tubing are made. In the event of bacterial contamination, the bacteria can migrate into the peritoneal cavity, In Barrington U.S. Patent NoO 3,986,50~, it is pro-posed that medical connector members may be sterilized after their connection, for example, with ultraviolet radiation~
By the invention of this application, a method and apparatus are provided for repeatedly or continuously pro-viding an antimicrobial effect on the connection junctions of tubing communicating between the above-described cathe-ter and connected solution container, with any contamin-ating bacteria being isolated in restricted areas after the connection is made. Antimicrobial ef~ect in these areas is accomplished by ultraviolet radiation. There-after, inner seals may be opened so that the system may be used to transfer solution from a container to the peri-toneal cavity of a patient.

Summary of the Invention In this invention, a connector valve is provided forselectively permitting the transfer of fluids there-through. The connector valve comprises multiple-way valve means, for example a three-way valve, communicating with a plurality of conduits and selectively permitting an preventing flow between the conduits. One of the conduits may communicate with a catheter leading to the peritoneal cavity of the patient, while the other conduits may be selectively connected to containers for providing or receiving fresh or spent peritoneal dialysis solution.
The multiple-way valve means comprises outer walls made of substantially ultraviolet-transmissive material, ~9 ~214;3~

and pre~erably enclosing an elastomeric seal member. The seal member defines a rotatable flow channel means for communication with different conduits at different rota-tional positions, and provides rotatable seal means 5 against inner surfaces of the outer walls to maintain antimicrobial conditions within the~ valve.
The ~low channel means is exposed along its entire length to an inner surface of an outer wall, so that the surfaces defining the flow channel means can receive the lO antimicrobial effect of ultraviolet radiation passing through these surfaces. Also, means are provided for rotating the seal member relative to the conduits for operation of the valve.
It is generally preferable for one or more of the con-15 duits to carry at their ends threaded means for receivingand fixedly retaining couplers connected to the fluid con-tainers (herea~ter called "bags"). These couplers may project into the threaded conduits, preferably to provide a sealing luer-type connection with the conduits in 20 addition to the threaded connection.
The couplers also have frangible means preventing flow through the couplers; the fra~gible means are openable to permit flow without disconnection from the conduits, with the outer surfaces of the couplers positioned within the 25 conduits to receive the antimicrobial effect of ultra-violet light passing through the valve means.
Thus, a connection may be made between the threaded conduits and the coupler means, and then the structure may be exposed to ultraviolet light, the ultraviolet light 30 having an antimicrobial effect on the e~terior surfaces o the couplers and the contaminated areas inside of the threaded conduits. After the structure has been exposed to ultraviolet li~ht for a time sufficient to have an antimicrobial effect, the frangible means can be opened without reopening the coupler means, so that a closed system is maintained.
Specifically, the frangible means preventing flow may be a diaphragm positioned at the end of each coupler within each conduit, and spaced from the threads of the coupler and conduit for easy exposure at its outer surface to ultraviolet light passing through the valve means.
Typically, spike means are positioned within the coupler, capable of being manually moved from the exterior to punc-10 ture the diaphragm after the antimicrobial exposure ofultraviolet light.
If desired, the coupler may be substantially opaque to ultraviolet light, thus being made of a less expensive material, since the interior portions of the coupler are sterilized at the factory. Thus, only the exterior por-tions of the coupler must receive the antimicrobial ef-fects o~ the ultraviolet light in the process described herein.
Tt is desirable for the area of the conduit defining the threads of the conduit to be thinner than the area of the coupler defining the threads o~ the coupler means.
This facilitates transmission of ultraviolet light into all nonsterile areas of the connected valve and coupler means, while at the same time the thicker portion of the threads of the coupler means provides sufficient mechan-ical strength for the device.
The spike may define a cut-away portion at its shar-pened end, with the sharpened end de~ining a pointed edge at one side of the spike opposite the cut~away portion.
As a result o~ this, the diaphragm is not cut away from the coupler interior wall at a certain area which is adjacent to the cut-away portion, and thus the diaphragm retains its attachment to the coupler interior wall. This prevents the diaphragm passing through the tubular system into the peritoneal cavity of the patient, or falling free to block flow at some point in tha system.
Also, stop means are carried by the coupler means to prevent overadvancement of the coupler means into the con-5 duits which, in turn, avoids stripping of the respectivethreads.
Furthermore, it is desirable for bellows means to be provided to permit longitudinal collapse of the coupler, which provides means for advancing the spike upon said collapse to penetrate the diaphragm after the anti-microbial effect of ultraviolet light on the immediate area of the connection..
The connector valve and conduits of this invention may be made of any substantially ultraviolet-transmissive 15 material which has adequate stability in the presence of the intense ultraviolet radiat'ion used herein to permit uRe for the desired period of time; the more transmissive the material is to ultraviolet light, the better. Pref-erably, connector valves and conduits may be made of a fluorocarbon material such as poly(trifluorochloroethane), for example, sold as KEL-F (by Minnesota Mining & Manu-facturing), or other appropriate and stable fluorocarbon materiaLs. The term "fluorocarbon materials" is not intended to exclude other chemical elements such as chlorine or hydrogen.
Alternatively, the connector valve and coupler means may be made of quartz, a highly transmissive material to ultraviolet radiation. Furthermore, silicone rubber, ap-propriately stabilized hydrocarbon resins, or other or~
ganic resins may be used as well.
The connector valve and adjacent connected conduits, after connection, may be placed into an u]traviolet light applicator to receive the antimicrobial effect of ultra-violet light. The applicator preferably comprises a ca~ing, as well as means permitting placement of the con-nector valve into the casing.

The inner surfaces of the casing are preferably of an ultraviolet-reflecting material, to increase th~ intensity and maximize the incidence from multiple directions of the ultraviolet light on the connector valve and adjacent con-5 nected conduits.
An elongated ultraviolet light element is preferablypositioned in the casing. The light element defines a plurality of convolutions, plus a channel between the convolutions o~ the element for receiving the connector 10 valve. The convolutions of the ultraviolet light element are preferably positioned on at least three sides of the channel, extending substantially along the channel to be capable of irradiating transversely-disposed interior surfaces of the connector valve and connected conduits, 15 such as the outer faces of the pierceable diaphragm and other transversely-disposed interior surfaces.
The ultraviolet light applicator pre~erably carries means for changing the various flow positions of a valve positioned in the applicator. Thus, the valve speci-20 fically described in this invention may be used to switchflow paths within the applicator without removing it from the ~ield of exposure to ultraviolet light.
A predetermined overall exposure of ultraviolet radia-tion is preferably at least 600,000 microwatt-sec-25 onds/cm2, specifically about 650,000 microwatt-sec-onds/cm2, applied to assure maximum antimicrobial effect within the interior of the connector valve and adjacent conduits. The overall exposure time of course will be in part a ~unction of the thickness and the ultraviolet 30 transmissivity of the material used to make the multiple-way valve means and connected conduits.
Furthermore, a method is provided of
2~

draining spent peritoneal dialysis solution from the peri-toneal cavity of a patient being treated by peritoneal di-alysis, and then adding fresh peritoneal dialysis solution to the same cavity, in a manner that decrease~ the like lihood of transmitting microbial contamination to the peritoneal cavit~ of the patient. The method comprises the steps of:
(a) connecting a first access port of a ~irst container filled with fresh peritoneal dialysis solution to a first connection port of a multiple-way valve means in communication with the patient's peritoneal cavity, said first access port and first connection port being both sealed at their inner ends to prevent migration of bacteria;
(b) connecting a second access port of an empty con-tainer to a second connection port of said multiple-way valve means in communication with the patient's peritoneal cavity, said second access port and second connection port being each sealed against migration of bacteria beyond a predetermined area, said predetermined area being spaced and sealed from the first access port and first connection port;
(c) flowing spent peritoneal dialysis solution from the patient's peritoneal cavity through said second con-nection port and second access port into said empty con-tainer while simultaneously exposing at least said first connection port and first access port to a sufficient quantity of ultraviolet radiation that an antimicrobial effect is obtained thereon;
td) closing said second connection port; and (e) opening the seal between said first connection port and said first access port to flow fresh peritoneal dialysis soution from the first container into the patient's pe.ritoneal cavity via said multiple-way valve means.

2~

The first connection port is preferably sealed during the drain phase with an unbroken diaphragm, and also the valve means is pre~erably closed to the first connection port, to isolate any contaminated area from the flow path~
A~ the result of this, as spent peritoneal dialysis solution from the patient's peritoneal cavity is flowing into the empty container, a process that can take about 10 to 20 minutes, the first connection port is in the process of receiving the antimicrobial effect of ultraviolet radi-lQ ation, so that when the drain phase has terminated, the spent, impurity-containing solution can be sealed in the formerly empty container, and the fresh dialysis solution can pass through the newly irradiated zone of connection, including the first connection port. Infusion of fresh dialysis ~olution occurs immediately after the drain phase, thus saving time.
The first and second access ports described in the method above may be provided by the conduits that communi-cate with the multiple-way valve means which is used to open and close the respective pathways of access, ~or example, the pathway of access of the spent dialysis solu-tion a~ter it has filled the empty container.
In one embodiment of the method of this invention, the empty container may be the initially-filled peritoneal dialysis solution container which was the source of the peritoneal dialysis solution administered to the patient.
During the "dwell phase" of the peritoneal dialysis solu-tion, amounting to several hours when the c~olution is in the patient, the patient is ambulatory, and may wear the flattened container under his clothes so that its con-nection is not disrupted. Accordingly, when the spent peritoneal dialysis solution flows from the patient's peritoneal cavity to the empty container it follows a previously irradiated path.

Just before the peritoneal dialysis solution i 5 drained from the peritoneal cavityr a fresh container of p~ritoneal dialysis solution may be connected to another connection port of the multiple-way valve, and this con-nection will then not be sterile. However, this con-nection remains isolated from the remainder of the system by the fact that the multiple-way valve is closed to it, so that as the spent peritoneal dialysis solution flows it encounters a previously irradiated path. At the same time, the nonsterile areas of the multiple-way valve and conduits receive antimicrobial radiation during the same period of tirne by exposure to the ultraviolet light, after which the valve is opened to the fresh container.
It is generally preferred when sterility is breached at both the first and second connection ports by the fresh addition of the full bag and a new, empty bag, to have a prior irradiation period of all of the nonsterile connec-tion area before initiating the drain phase from the peritoneal cavity to the empty container.

Brief Descri~_ion o~ the Drawings In the drawings, Figure l is a detailed plan view, taken partly in longitudinal section, of a peritoneal dialysis set in accordance wih this invention, with some portions thereof being shown schematically and in reduced scale.
Figure 2 is a fragmentary, longitudinal sectional view of the multiple-way valve of the set o Figure 1.
Figure 3 is an enlarged, longitudinal sectional view of a portion of the set of this invention, showing a threaded conduit in connection with the coupler means, prior to rupturing of the frangible diaphragm by the spike.
Figure 4 i~ a similar longitudinal sectional view of the structure of Figure 3, after rupturing of the dia-phragm by means of the spike.

Figure 5 is a fragmentary elevational view of part of an alternate set of this invention, taken partly in longi-tudinal section, showing the arrangement of the various convolutions of the elongated ultraviolet light element relative to the multiple-way valve and connected conduits when the multiple-way valve is positioned in the ultra-violet light applicator.
Figure 6 is a plan view of the specific ultraviolet light element utilized in the embodiment of Figure 5.
Figure 7 is a view of the ultraviolet light element of Figure 6, taken along line 7-7 of Figure 6.
Figure 8 is a view of the ultraviolet light element, taken along line 8-8 of Figure 6.
Figure 9 is a plan view of the ultraviolet light ap-plicator utilized in this invention, containing one of thesets disclosed herein. Figure lO is a front elevational view of the ultra~
violet light app]icator of Figure 9.
Figure 11 is a side elevational view of the ultra-violet light applicator of Figure 9.
Figure 12 is a detailed plan view, taken partly inlongitudinal section, of the peritoneal dialysis set shown partially in Figure 5, with some parts shown schematically.
Figure 13 is a fragmentary, longitudinal sectional 25 view of the multiple-way valve of the set of Figure 12, taken along line 13-13 of Figure 12.

Description of the Preferred Embodiment _ Referring to Figures l and 2, a connector valve ll is shown, being made in accordance with this invention to facilitate repeated connection and disconnection during peritoneal dialysis procedures, while substantially sup-pressing the risk of transmitting infectious bacteria into the peritoneal cavity.

Catheter 10 may be surgically implanted into the peritoneal cavity of the patient, with connector member 12 of conventional design being carried at an end there-of. Connector member 12 and catheter 10 may be con-structed to be a generally permanent implant for thepatient, with the connector 12 being preferably made of metal such as titanium for example, and catheter 10 being of durable silicone rubber for permanence and long life.
Tubing 20 permanently communicates with ultra-violet antimicrobial connector valve 11 as shown, withtubing 20 being sealed to por-t member 21, which may be an integral part of connector valve 11.
At the other end of tubing 20, a second con-nector 14 is provided, being optionally made of thermo-15 ~ plastic material and proportioned to form a sealed con-nection with connector member 12, which is carried at the end of catheter 10. Typically, connectoxs 12 and 14 may be of the design disclosed in Dennehey, e-t al. U.S.
Patent No. 4,346,703, issued August 31, 1982 to Baxter Travenol Laboratories, Inc.
It is generally intended that tubing 20 and con-nector valve 11 will be connected to connector member 12 at a clinic or a hospital, with the connection operation being performed under aseptic conditions. Tubing 20 and connector valve 11 are then used on a frequent basis for a period of time, for example, about a month without dis-connection of connector member 12 and second connec~or 14~ Then, connectors 12, lq are disconnected, once again at the clinic ullder aseptic conditions, and a ~resh set comprising connector valve 11, tubing 20, and connector 14 are connected under the same aseptic conditions to connector member 12.
The relatively inexpensive set comprising tubing 20 and connector valve 11 may be subjected to ultraviolet radiation several times a day for a period of about a month, then being replaced before damage caused by the ultraviolet radiation to the material of connector valve 11 and other parts becomes excessive.
The ultraviolet radiation technique may be performed in the home by the patient or his family in the period between visits to the clinic when the connection between connector members 12 and 14 is made. This assures an antimicrobial connection with the bags of solution and drainage bags for frequent peritoneal dialysis solution exchanges after the user has been trained, without the need for the constant attention of a physician or a trained nuræe.
As shown in the drawings, connector valve 11 comprises a housing 23, which may be made of a generally ultraviolet transmissive material such as KEL-F. Housing 23 further defines a pair of connector arms 24, 26 which may project outwardly from housing 23 at any desired anqle, but pre-ferably to form a parallel connection with tubing 20 as shown in Figures 1 and 2, a T connection as shown in Figures 12 and 13, or alternatively, a Y connection.
Connector arms 24, 26 each comprise generally rigid tubular structures defining a receptacle at their outer ends having helical female threads 28 proportioned to receive a penetrating coupler 30 which, in turn, defines projecting helical threads 32 to mate with threadæ 28 for sealing a penetrating coupler 30 to either connec~or arm 24 or 26. Each of penetrating couplers 30 i~ solvent sealed, heat sealed, or the like to flexible tubing 34, which may be made of polyvinyl cloride or the like.
Tubing 34, in turn, may connect to a sealed container 36, 36a which may be of conventional design. As can be seen from Figure 1, connector valve 11 is accordingly in flow connection through each of :its connector arms 24, 26 to separate containers 36, 36a. One of the containers 36, ~32~4;~

36a may serve as a source of peritoneal dialysis solution, while the other of the containers ma~ be empty, and serves as a receptacle for spent peritoneal dialysis solution.
For example, container 36a may be a collapsible bag which the patient can carry under his clothes, or alternatively, the patient can disconnect bags 36, 36a and cover the ports of connector valve 11 with protective caps.
Each of the penetrating couplers 30 has a diaphragm 38, preferably at its inner end, as shown. Freely movable, hollow spike member 40 is also provided in each of the coupler members 30. Hollow spike member 40 may be pushed inwardly by manual manipul~ation of plastic bellows portions 42 of tubing 34, to cause the pointed end of spike 40 to rupture diaphragm 38, when it is desired to open a connection between container 36 and connector ll.
Connector valve ll defines a preferably elastomeric stopcock seal member 44, which is a rotatable member of generally circular structure, fitting within cylindrical housing 23 as part of connector valve ll, and carried by rotatable outer closure 47. Projections 48 provide her-metic sliding sealing contact between member 44 and hous-ing 23.
Groove 50 is defined by one face of stopcock seal member 44, to rotate with the rotation of the seal member 44, to provide an on-off flow connection between tubing 20 and connector arms 24, 26. Accordingly, when diaphragm 38 is ruptured, peritoneal dialysis solution from container 36 can pass through groove 50 into tubing 20, and thus into catheter lO and the peritoneal cavity of the patient, when seal member 44 is in the position as shown in Figure l. This can be used during the infusion phase of CAPD.
Seal member 44 may then be rotated so that no flow can pass through the connector valve ll, for example, during the dwell phase of CAPD.

1~

Thereafter, when it is desired to drain the spent peritoneal dialysis solution from the patient (CAPD drain phase), seal member 44 may be rotated so that groove 50 connects between tubing 20 and connector arm 26. The spike 40 of connector arm 2~ may be advanced as in the previous manner to open a flow path between the patient's peritoneal cavity and the bag 36a connected therewith for receiving the drained peritoneal dialysis solution.
Thereafter, seal member 44 can be rotated again so that an additional portion of peritoneal dialysis solution may pass from a new bag 36 into the peritoneal cavity oE
the patient.
When it is desired to disconnect one or more of the penetrating couplers 30, seal member 44 is simply rotated to isolate the appropriate connector arm 24 and/or 26 from groove 50, so that any contamination remains isolated in the respective connector arm upon opening.
As long as there is the possibility of the existence of contamination in either of connector arms 24, 26, seal member 44 should remain in a position to isolate that con-nector arm.
The structure of this invention may be then recon-nected to a new projecting coupler 30 and its attached container 36 or 36a. Then, before seal member 44 is rotated, connector valve 11, including connector arms 24, 26~ is exposed to an ultraviolet radiation source, pref-erably of a wavelength of about 254 nanometers, the anti-microbial wavelength of ultraviolet light, with the radia-tion passing through bottom wall 52 o~ housing 23 and other directions. An overall dosage of about 0.6 watt'second/cm or more may be provided for each irradiation with the ultraviolet radiation also passing through the projecting connector arm walls 24, 26. As stated above, these structures may comprise an integral Z~3 piece, and they are made of a material having ~ubstantial transparency ~o the ultraviolet radiation used. ~s a result of this, the area within housing 23 and projecting arms 24, 26 are s~bjected to the antimicrobial effect of ultraviolet radiation including the outside surfaces of penetrating couplers 30.
It is preferred for the ultraviolet radiation to be applied to both the top and bottom of the connector valve 11, particularly in the area of the coupler members 30.
If desired, tubing 20 may also be made of a material as described herein and exposed to ultraviolet radiation.
Otherwise, it may be made of polyvinyl chloride or the likeO
The exterior surfaces of diaphragms 38 should also re-ceive the antimicrobial effect of ultraviolet radiation.To facilitate this, diaphragm 38 may be positioned at the outer end of coupler 30, so that all nonsterile surfaces are easily exposable to ultraviolet light. It is to be under~tood that the interior portions of coupler member 30 remain sterile as long as diaphragm 38 is not broken, so the couplers 30 do not have to be made of an ultraviolet transparent material, although they may be so if desired.
Furthermore, groove 50 is exposed along its entire length to bottom wall 52 of housing 23, so it will receive antimicrobial radiation as well as the entire area inside of housing 23, although it is contemplated that contamina-tion would not extend that far into the connector i~
proper procedure is used, because o~ the sealing areas 48.
Stopcock seal member 44 may, as shown in Figure 2, comprise outer closure 47, attached to housing 23 by an interlocking ~lange structure 49 of conventional design, to provide a sealed but rotatable structure. Also, seal member 44 may be provided underneath closuxe 47, and attached thereto, being preferably made of silicone rubber to serve as a seal.

~L18Z~3 The connector members of this invention may be of any desired design, with the multiple-way valve connector structure as shown being only one particularly contem-plated design. For example, luer~type connectors having flexible tubing that is pinched closed, with the ultra-violet radiation taking place after connection but beEore opening the pinch closures, constitutes another type of design in which the couplers of this invention may be used. Also, internal breakaway seals may be used of the 10 general type shown in U.S. Patent No. 4,181,140 in place of diaphragms 38.
Also, the connector of this invention may be utilized in procedures other than peritoneal dialysis, to facili-tate the antimicrobial effect of ultraviolet radiation in other products and processes, such as parenteral solution administration in general and the like. Connector valves made with the materials as described in this invention may be reconnected and disconnected, with ultraviolet radia-tion providing repeated, reliable antimicrobial effect in the connector valve interior.
The ultraviolet irradiation may take place while spent peritoneal dialysis solution is flowing into bag 36a, to save time in the process, 90 that fresh peritoneal dialysis solution may pass ~rom bag 36 into the patient's peritoneal cavity promptly after the drainage step. It is also desirable, but not necessary, for the ultraviolet irradiation to continue while the solution i9 passing from bag 36 into the patient 1 5 peritoneal cavity.
Referring to Figure~ 3 ~nd 4, longitudinal sectional views of the connection between connector arm 26 and its associated coupler member 30 are shown, Figure 3 showing spike 40 in its original configuration, and Figure 4 show-ing spike 40 in its advanced configuration when a flow 4~

path is opened through the connector and coupler. The de-tails of structure shown are typically similar to con-nector arm 24 and its associated coupler 30.
It is preferred for the area of connector arm 26 which defines internal t~reads 28 to be of less thickness than the area of coupler member 3n which defines the threads 32 of the coupler member, engaging threads 28. Accordingly, there is less thickness o~ material in coupler arm 26 than would otherwise be present, which facilitates the tran-smission of ultraviolet radiation to the junction 60between the respective threads.
Spike member 40 may.also define a cut-away portion 62 at its sharpened end 64, with the sharpened end 64 defining a pointed edge at one side of spike 40, as shown, which is opposed to cut-away portion 62. As the result of this, diaphragm 38 is not completely cut away from coupler means 30 as spike 40 is advanced as in Figure 4, but retains its attachment to at least one position 66 so that the diaphragm 38 is not cut completely loose from the assembly.
An annular stop flange 68 is also defined on coupler 30, to prevent overadvancement of screw-threaded travel by the coupler, to prevent stripping of threads 28.
It should also be noted that, as an additional seal between coupler 30 and connector arm 26, coupler 30 defines a slightly tapered, cylindrical portion 70 to sealingly fit within connector arm 26 with a luer-type seal, to assure that no contamination can enter the system while coupler 30 and connector arm 26 are in engaged rela-tion.
After connector arm 26 and coupler member 30 have beenirradiated with ultraviolet light, the system may be opened by manually grasping sleeve 72 of coupler 30 and collapsing it into the configuration of Figure 4. Spike 40 is advanced through diaphragm 38 b~ the pressure o~
annular seat 73 against enlarged end 74 of hollow spike 40. Spike 40 may be proportioned so that it slidas through the bore of coupler member 30 with a measure of frictional resistance, so that it will be positively retained in any desired axial position, to prevent acci-dental withdrawal o~ the spike, which could release dia-phragm 38 and allow it to occlude flow through the system.
Fin members 76 may be provided, for example four of such fins spaced 90 apart, as a gripping aid to aid in the coupling and uncoupling of members 26, 30.
Referring to Figure$ 5 through 13, details of how the structure of this invention may be ultraviolet irradiated are shown. Figures 12 and 13 disclose details of another embodiment of peritoneal dialysis æet in accordance with this invention, in which the reference numerals are iden-tical with the reference numerals of Figures 1 and 2, and point to the corresponding and similar structures of Fig-ures 12 and 13. The set of Figures 12 and 13 functions in a manner w~ich is similar to the functioning of the set of Figures 1 and 2 as previously described, with the excep-tion that the connector arm 24, 26 in Figures 12 and 13 are opposed to each other rather than parallel as in Figures 1 and 2.
Figures 5 through 11 show details of the ultraviolet irradiation apparatus which is adapted ~or use in conjunction ~ith the set o~ Figures 12 and 13.
In Figure 5, connector valve 11 is ~hown w~th con-nector arms 2~, 26 being attached to coupler members 30.
Valve 11 and connected structures are positioned in an ultraviolet light applicator or "box" as disclosed in Figures 9 through 11. The applicator includes a casing 80, shown in phantom in Figure 5. Hinged hatch means 82 ~18~ 3 permits placement of the connector valve 11 and the at-tached arms o~ conduits 24, 26 into the housing 80. The inner surface of housing 80 may be of an ultraviolet-reflecting material 84, for example, an etched aluminum coating to maximize the exposure of ultraviolet light by the contentæ of the applicator.
In accordance with this invention, an elongated ul-traviolet light element 86 is provided in the housing 80, defining a plurality of convolutions 88 through 92, The convolutions 88 through 92 are positioned to define a channel 94 which is proportioned for receiving connector valve 11 and connector arms 26, 28 with the convolutions 88 through 92 being positioned on at least three sides of the channel, and extending substantially along the channel so that ultraviolet light is propagated from a continuum of positions along the channel. Thus, the ultraviolet light source is capable of irradiating the transversely disposed interior surfaces of the system, for example, the oute- surface of each of diaphrams 38, prior to rupturing, with at least a portion of ultraviolet source 86 defining an angle to the plane of each diaphragm 3~3 of about 20 to 60, for direct irradiation thereof.
Because ultraviolet light element 86 is elongated and propagates its ultraviolet light from a continuum of sources, there can be no nooks or crannies capable of contact with the liquid flow paths inside of valve ll or connector arms 24, 26 which are unexpoqed to the ultra-vio~et light.
Particularly, convolution 91 o the ultraviolet light 01ement is po~itioned to irradiate ultraviolet light onto the outer, nonsterile surface of membrane 38, on the op-posite side from the corresponding spike member 40 in arm 26. Convolution 89 is similarly positioned for the irra-diation of the other diaphragm 38 positioned by coupler 30 21~

into connector arm 28 prior to ruptuxe by spike 40. These convolutions also irradiate bottom wall 52 of connector valve 11.
Convolutions 88 and 92 irradiate the tops of coupler arms 24, 26, 90 that at least the great majority of the sealed connection between each coupler member and con-n~ctor arms 26, 28 is irradiated. Convolution 90 provides additional lateral ultraviolet irradiation, while the ultraviolet radiation propagated from all of the element 86 is reflected off the housing walls 80 o~ the applicator back to the valve 11 from a multitude of angles and directions, for complete irradiation of the interior por~
tions thereof.
Control knob 96 i5 provided, communicating with inter-locking projPction 98 of interlocking housing portion 47,so that seal member 44, which is attached to housing por-tion 47, may be rotated by rotation of the control knob 96 to control the position of flow channel 50; the control knob 96 may be permanently attached to the box or detach-able ~rom the box. As shown in Figure 5, flow channel 50is directly exposed to ultraviolet transmission through bottom wall 52 for sterilization of the internal portions of channel 50.
Ultraviolet light element 86 is preferably of a gen-erally h-shape when viewed along a dimension as shown in Figure 8, and it also may be generally of a w-shape when viewed along the dimension as shown in Figure 7.
While preferably five specific convolutions are used in the specific ultraviolet element 86 illustr~ted herein, ultraviolet elements having more or less than five con--volutions may also be utilized in this invention to obtain a large, multi-dimensional continuum of sources of ultra-violet radiation for having an antimicrobial effect on the connector system.

~8~3 It is also preferred for a photocell 87 to be provided within housing 80 to measure the total energy of ultra-violet light applied in each sterilization procedure.
When tne total energy reaches the predetermined overall desired exposure level, for example 0.6 watt-sec/cm , the photocell means activates a transducer connected to the photocell to shut off the ultraviolet light element.
Accordingly, the sterilizing process of this invention does not have to use a timing sequence or the like, which can be inaccurate since ultraviolet elements can signi-ficantly change the intensity of their propagation of ultraviolet radiation. Instead, the applicator can operate until the predetermined total energy of ultra-violet exposure is emitted, following which the apparatus is activated to shut off.
Accordingly, connector valve 11 with its arms 21, 24, 26 may be placed into housing 80 for ultraviolet irradia-tion, with each of connector arms 24, 26 being connected to a coupler 30 which, in turn, connects to bags 36, 36a in aseptic manner.
In the use of the device of this invention, as pre-viously described, tubing 20 communicates with connector valve 11. Tubing 20 terminates with coupler 14, which is aseptically connected to coupler 12 of implanted catheter 10. After connection with a coupler 30 and bag 36 to arm 24 and after ultraviolet irradiation has appropriately proceeded, spike 40 within arm 24 i9 advanced to rupture the associated membrane 38, and the peritoneal dialysis solution of container 36 is transferred to the peritoneal cavity by passage through channel 50, tube 20 and catheter 10 .
Sealing member 44 may then be rotated so that channel 50 communicates with no conduit, to seal off all of the conduits.

~821g!~3 If desired, bag 36 may be retained under the clothes during the dwell phase of the peritoneal dialysis solution in the peritoneal cavity. The other arm 26 is typically sealed ~nder this circumstanoe and free of connection with a coupler 30. Thus, the patient is free to go about normal daily activities, with connector valve 11 and the flat bag 35 worn under his or her clothes~
At the termination of the several hour dwell phase for the peritoneal dialysis solution, the patient is free to go about normal daily activities, with connector valve 11 and the flat bag 36 worn under his or hex clothes.
At the termination of the several ho~r dwell phase for the peritoneal dialysis solution, the patient can remove connector valve 11 and bag 36 from un~er his or her clothes, connect a coupler and bag 36a of fresh solution to arm 26, and insert the connector valve 11 once again into housing 80 for ultraviolet irradiation. Sealing member 44 can be moved, controlled by knob 98, once again so t~at channel 50 communicates between tubing 20 and arm 24, with the result that spent peritoneal dial~ysis solution flows from the peritoneal cavity back to bag 36, while the ultraviolet element 86 in housing 80 irradiates the entire connector valve 11 and arms 24, 26. The path of flow remains closed if proper procedure has been used, so that channel 50 has not been exposed to the passageway inside of arm 26, with a barrier being produced by sealing projections 4a against the interior of casing 23. Thus, any nonsterile contamination remains i.solated, for example in area 100 (Figure 12).
During the time o~ outflow of peritoneal dialysis solution into bag 36 along its closed pathway, the ultra violet radiation passing into the interior of valve 11, including arms 24, 26, provides an antimicrobial effect on the enclosed areas therein, including area 100 and any other pockets of contamination that may exist, for example area 102 resulting from the rotation of seal member 44, prior to which rotation area 102 communicated with arm 26.
At the termination of the drainage and ultraviolet radiation step, knob 98 is turned to rotate ~eal member 44 so ~hat channel 50 communicates between connector arm 26 and tubing 20, with the result tha~ fresh peritoneal dialysis ~olution from bag 36a can flow into the patient's peritoneal cavity. At the same time the flow connection between bag 36 and the peritoneal cavity is terminated with the seal provided by seal member 44.
After the contents of bag 36a have drained into the patient's peritoneal aavity, bag 36 and its associated coupler 30 may be removed which, of course, exposes the interior of arm 24 to potential contamination. However the contamination is limited by the position of seal 44, so that it can only find its way into one or two of the pockets analogous to pockets 100, 102, which remain iso-lated from the then flow path communicating with the peri-toneal cavity.
Following this, without further rotation of sealingmember 44, connector valve 11 may be removed from the ultraviolet applicator, and flat bag 36a and connector valve 11 may be placed under the clothes of the patient, for him to resume his normal activities until it is time to repeat the process, utilizing bag 36a as the drainage bag. A new bag 36 and coupler 30 may be attached to arm 24, followed preferably by drainage from the peritoneal cavity into bag 36a ~imultaneously with irradiation of the system as before, ~o that the flow path between new bag 36 and the peritoneal cavity may be irradiated by ultraviolet light prior to its use.
Alternatively, after placement of the peritoneal dialysis solution into the peritoneal cavity, one may 2~

remove both bags 36, 36a and their couplers 30, after turning seal member 44 to a position that prevents flow through and seals all of its flow paths. In this in-stance, when it is desired to change the peritoneal dialysis solution, one connects new pairs of bags 36, 36a, with their respective couplers, placing connector valve 11 into ultraviolet applicator housing 80 for typically a ten minute application of ultraviolet radiation prior to mov-ing seal member 44 into a connecting position with a pass-ageway for draining of the peritoneal dialysis solution.
The above has been offered for illustrative purposesonly, and is not intende~d to limit the scope of the inven-tion of this application, which is as defined in the claims below.

Claims (5)

THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. An ultraviolet light applicator for irradiating a connector valve and adjacent connected conduits, for selectively permitting the transfer of fluids there-through, said applicator comprising a casing, means per-mitting placement of said connector valve into said casing, the inner surfaces of said casing being of an ultraviolet-reflecting material, and an elongated ultra-violet light element in said casing defining a plurality of convolutions plus a channel between said convolutions of the element for receiving the connector valve, said convolutions being positioned on at least three sides of said channel and said convolutions extending sub-stantially along said channel, said convolutions being capable of irradiating by ultraviolet light the trans-versely-disposed interior surfaces of said connector valve and connected conduits.
2. The ultraviolet light applicator of claim 1 in which said elongated, ultraviolet element is generally of an h-shape when viewed along one dimension.
3. The ultraviolet light applicator of claim 2, in which said elongated, ultraviolet element is generally of a w-shape when viewed along another dimension.
4. The ultraviolet light applicator of claim 3 in which said elongated, ultraviolet element has at least five convolutions.
5. The ultraviolet light applicator of claim 1 in which means are carried by said applicator for switching various flow positions of a valve positioned in said applicator.
CA000400135A 1981-06-05 1982-03-31 Antimicrobial ultraviolet irradiation of connector for continuous ambulatory peritoneal dialysis Expired CA1182143A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US270,743 1981-06-05
US06/270,743 US4412834A (en) 1981-06-05 1981-06-05 Antimicrobial ultraviolet irradiation of connector for continuous ambulatory peritoneal dialysis

Publications (1)

Publication Number Publication Date
CA1182143A true CA1182143A (en) 1985-02-05

Family

ID=23032612

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000400135A Expired CA1182143A (en) 1981-06-05 1982-03-31 Antimicrobial ultraviolet irradiation of connector for continuous ambulatory peritoneal dialysis

Country Status (14)

Country Link
US (2) US4412834A (en)
EP (2) EP0175428B1 (en)
JP (2) JPS58501158A (en)
AU (1) AU553771B2 (en)
BR (1) BR8207737A (en)
CA (1) CA1182143A (en)
DE (2) DE3278100D1 (en)
DK (1) DK161801C (en)
ES (1) ES512764A0 (en)
IL (2) IL65673A (en)
IT (1) IT1152221B (en)
MX (1) MX152084A (en)
WO (1) WO1982004187A1 (en)
ZA (1) ZA823927B (en)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4655762A (en) * 1980-06-09 1987-04-07 Rogers Phillip P Ambulatory dialysis system and connector
US4620845A (en) * 1981-06-05 1986-11-04 Popovich Robert P Method of peritoneal dialysis involving ultraviolet radiation of dialysis apparatus
US4738668A (en) * 1981-07-29 1988-04-19 Baxter Travenol Laboratories, Inc. Conduit connectors having antiseptic application means
IE54194B1 (en) * 1982-06-30 1989-07-05 Boots Co Plc Medical connector
US4614514A (en) * 1983-02-16 1986-09-30 M/A Com, Inc. Microwave sterilizer
US4500788A (en) * 1983-08-19 1985-02-19 Baxter Travenol Laboratories, Inc. Device for providing antibacterial radiation
JPS61113468A (en) * 1984-11-06 1986-05-31 テルモ株式会社 Medical appliances
US4769017A (en) * 1985-04-04 1988-09-06 Fath John J Self-sealing infusion manifold and catheter connector
US4655753A (en) * 1985-11-27 1987-04-07 Baxter Travenol Laboratories, Inc. Connection device
US4801091A (en) * 1988-03-31 1989-01-31 Sandvik Arne P Pulsating hot and cold shower head
US4882496A (en) * 1988-04-29 1989-11-21 Baxter International Inc. Apparatus for exchanging and irradiating tubing connections
KR0137969B1 (en) * 1989-05-03 1998-04-30 죤 에프. 가이더, 제이 알. Frangible spike connector for a solution bag
US5184020A (en) * 1989-10-26 1993-02-02 Hearst David P Device and method for photoactivation
US6146600A (en) * 1993-09-17 2000-11-14 University Of Hawaii Side body disingestation chamber
NZ271896A (en) * 1993-09-17 1998-02-26 Univ Hawaii Pest treatment chamber; apparatus for killing pests on or in flowers, fruit or vegetable commodities; use of hot air with a relative humidity of 30-85%
US5360395A (en) 1993-12-20 1994-11-01 Utterberg David S Pump conduit segment having connected, parallel branch line
US5579757A (en) * 1994-02-02 1996-12-03 Baxter International, Inc. Anti-siphon flow restricter for a nebulizer
SE504779C2 (en) * 1994-09-07 1997-04-21 Danfoss As Sampling device with membrane and membrane holder
US5768853A (en) * 1996-02-15 1998-06-23 Purepulse Technologies, Inc. Deactivation of microorganisms
US5931801A (en) * 1997-01-21 1999-08-03 Vasca, Inc. Valve port assembly with interlock
JP3121302B2 (en) * 1997-11-04 2000-12-25 三共電気株式会社 Irradiation type sterilizer
DE29809867U1 (en) * 1998-06-04 1998-09-24 Buettner Klaus UV lamp for hemodialysis
US6736797B1 (en) * 1998-06-19 2004-05-18 Unomedical A/S Subcutaneous infusion set
DE69912849T2 (en) 1998-12-23 2004-09-02 UV-solutions, LLC, Wellesley Hills METHOD AND DEVICE FOR STERILIZING SMALL OBJECTS
CA2436593A1 (en) * 2000-12-14 2002-07-25 Uv-Solutions, Llc Method and apparatus for rapidly sterilizing small objects
WO2002076513A1 (en) * 2001-03-27 2002-10-03 Uv-Solutions, Llc. Method and apparatus for rapidly sterilizing irregularly-shaped objects
EP2295112A1 (en) * 2001-06-15 2011-03-16 UV-Solutions, LLC Apparatus for sterilizing or disinfecting a region through a bandage
US7232429B2 (en) * 2002-04-08 2007-06-19 Boston Scientific Corporation Medical devices
EP1560622B1 (en) * 2002-07-09 2008-03-05 Carmel Pharma AB A device for injecting medical substances
US7195615B2 (en) * 2003-05-14 2007-03-27 Boston Scientific Scimed, Inc. System for providing a medical device with anti-microbial properties
ITPE20040004A1 (en) * 2004-02-27 2004-05-27 Paolo Cerasoli CONNECTOR FOR PERITONEAL DIALYSIS WITH REMOVAL OF THE SEALING PIN USED IN A STERILE ENVIRONMENT SUCH AS TO ENSURE A CONNECTION AND A DISCONNECTION OF THE DIALYTIC EXCHANGE LINE FROM THE PERITONEAL CATHETER TOTALLY PROTECTED FROM CONTAMINATION
ATE525101T1 (en) 2004-02-27 2011-10-15 Glomeria Therapeutics S R L DEVICE FOR ATTACHING AND REMOVING A CLOSURE ON AN END PART OF A TUBULAR ELEMENT FOR PERITONEAL DIALYSIS
US7520919B2 (en) * 2004-06-22 2009-04-21 Gambro Lundia Ab Transducer-protector device for medical apparatus
FR2874816B1 (en) * 2004-09-08 2006-12-08 Guerbet Sa STORAGE ASSEMBLY FOR CONTRAST PRODUCTS
US8197087B2 (en) * 2007-07-05 2012-06-12 Baxter International Inc. Peritoneal dialysis patient connection system using ultraviolet light emitting diodes
US8764702B2 (en) 2007-07-05 2014-07-01 Baxter International Inc. Dialysis system having dual patient line connection and prime
US7909795B2 (en) 2007-07-05 2011-03-22 Baxter International Inc. Dialysis system having disposable cassette and interface therefore
US8157761B2 (en) * 2007-07-05 2012-04-17 Baxter International Inc. Peritoneal dialysis patient connection system
US7955295B2 (en) * 2007-07-05 2011-06-07 Baxter International Inc. Fluid delivery system with autoconnect features
US7736328B2 (en) 2007-07-05 2010-06-15 Baxter International Inc. Dialysis system having supply container autoconnection
US8496609B2 (en) 2007-07-05 2013-07-30 Baxter International Inc. Fluid delivery system with spiked cassette
US9348975B2 (en) * 2008-05-02 2016-05-24 Baxter International Inc. Optimizing therapy outcomes for peritoneal dialysis
US8882700B2 (en) 2008-05-02 2014-11-11 Baxter International Inc. Smart patient transfer set for peritoneal dialysis
US8178120B2 (en) 2008-06-20 2012-05-15 Baxter International Inc. Methods for processing substrates having an antimicrobial coating
US8753561B2 (en) 2008-06-20 2014-06-17 Baxter International Inc. Methods for processing substrates comprising metallic nanoparticles
US8277826B2 (en) 2008-06-25 2012-10-02 Baxter International Inc. Methods for making antimicrobial resins
ES2382178T3 (en) * 2008-07-29 2012-06-06 Mallinckrodt Llc Ultraviolet sterilizer for tube connector
US9044544B2 (en) 2008-11-21 2015-06-02 Baxter International Inc. Dialysis machine having auto-connection system with roller occluder
US20100130918A1 (en) * 2008-11-21 2010-05-27 Baxter International Inc. Systems and methods for removing air from supply containers and associated fill tubing
US8377012B2 (en) * 2009-01-30 2013-02-19 Baxter International Inc. Transfer sets for therapy optimization
US20100227052A1 (en) 2009-03-09 2010-09-09 Baxter International Inc. Methods for processing substrates having an antimicrobial coating
US8574490B2 (en) * 2009-03-31 2013-11-05 Bactriblue, Ltd. Methods and apparatus for reducing count of infectious agents in intravenous access systems
US8617465B2 (en) 2009-09-15 2013-12-31 Baxter International Inc. Dialysis connector and cap compatible with gas sterilization
US8585681B2 (en) 2010-05-10 2013-11-19 Puracath Medical, Inc. Systems and methods for increasing sterilization during peritoneal dialysis
US9282796B2 (en) 2010-05-19 2016-03-15 Johnson & Johnson Vision Care, Inc. UV radiation control for disinfecting of ophthalmic lenses
US20110284773A1 (en) * 2010-05-19 2011-11-24 Pugh Randall B Germicidal bulb disinfection base for ophthalmic lenses
US20110284764A1 (en) 2010-05-19 2011-11-24 Pugh Randall B Ophthalmic lens disinfecting base
US9907897B2 (en) * 2011-03-23 2018-03-06 Nxstage Medical, Inc. Peritoneal dialysis systems, devices, and methods
US8980174B2 (en) 2011-05-13 2015-03-17 Bactriblue, Ltd. Methods and apparatus for reducing count of infectious agents in intravenous access system
US9700672B2 (en) 2011-09-21 2017-07-11 Bayer Healthcare Llc Continuous multi-fluid pump device, drive and actuating system and method
JP6223959B2 (en) * 2012-03-12 2017-11-01 テルモ株式会社 Blood channel switching device and blood bag system
US10307612B2 (en) 2012-04-05 2019-06-04 Light Line Medical, Inc. Methods and apparatus to deliver therapeutic, non-ultraviolet electromagnetic radiation to inactivate infectious agents and/or to enhance healthy cell growth via a catheter residing in a body cavity
US9808647B2 (en) 2012-04-05 2017-11-07 Veritas Medical, L.L.C. Methods and apparatus to inactivate infectious agents on a catheter residing in a body cavity
US11497932B2 (en) 2012-04-05 2022-11-15 Light Line Medical, Inc. Electromagnetic radiation delivery and monitoring system and methods for preventing, reducing and/or eliminating catheter-related infections during institutional or in-home use
US10894173B2 (en) 2012-04-05 2021-01-19 Light Line Medical, Inc. Methods and apparatus to deliver therapeutic, non-ultraviolet electromagnetic radiation to inactivate infectious agents and/or to enhance healthy cell growth via a catheter residing in a body cavity
US11229728B1 (en) 2020-08-24 2022-01-25 Light Line Medical, Inc. Method and apparatus to deliver therapeutic, non-ultraviolet electromagnetic radiation in a dialysis system
US11229808B2 (en) 2012-04-05 2022-01-25 Light Line Medical, Inc. Methods and apparatus to deliver therapeutic, non-ultraviolet electromagnetic radiation versatilely via a catheter residing in a body cavity
US9295742B2 (en) 2012-04-16 2016-03-29 Puracath Medical, Inc. System and method for disinfecting a catheter system
US20140154297A1 (en) 2012-10-30 2014-06-05 Baxter Healthcare S.A. Antimicrobial substrates and methods for processing the same
JP5879635B2 (en) * 2013-01-24 2016-03-08 株式会社Lixil Pulse shower device
WO2014120620A1 (en) 2013-01-29 2014-08-07 Puracath Medical, Inc. Apparatus and method for disinfecting a catheter
US11007361B2 (en) * 2014-06-05 2021-05-18 Puracath Medical, Inc. Transfer catheter for ultraviolet disinfection
AU2016205275B2 (en) 2015-01-09 2020-11-12 Bayer Healthcare Llc Multiple fluid delivery system with multi-use disposable set and features thereof
JP2018513720A (en) * 2015-03-18 2018-05-31 プラキャス メディカル インコーポレイテッド Catheter connection system for UV sterilization
WO2017109760A1 (en) * 2015-12-24 2017-06-29 Ellen Medical Devices Pty Ltd Treatment fluid preparation system
US10525249B2 (en) 2016-03-07 2020-01-07 Fenwal, Inc. System and method for creating sterile connections using ultraviolet light
CN110049790A (en) * 2016-07-11 2019-07-23 普拉卡斯医疗公司 Conduit connection systems for disinfection by ultraviolet light
US10688207B2 (en) 2016-08-02 2020-06-23 C. R. Bard, Inc. High energy visible light-based disinfection of medical components
US9925285B1 (en) * 2017-06-21 2018-03-27 Inikoa Medical, Inc. Disinfecting methods and apparatus
CN108355189A (en) * 2018-02-07 2018-08-03 温州市中心医院 A kind of peritoneum dialysis catheter
CA3092575A1 (en) 2018-02-28 2019-09-06 Nxstage Medical, Inc. Fluid preparation and treatment devices, methods, and systems
US10765767B2 (en) 2018-06-19 2020-09-08 Inikoa Medical, Inc. Disinfecting methods and apparatus
EP3888734A1 (en) 2020-04-02 2021-10-06 Fenwal, Inc. Reversible sterile connection system
US11484636B2 (en) * 2020-04-16 2022-11-01 Fresenius Medical Care Holdings, Inc. Medical device having integrated sterile work platform
US20230285734A1 (en) 2022-03-14 2023-09-14 Fenwal, Inc. Reversible sterile connection system

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1896379A (en) * 1930-11-17 1933-02-07 James C Ross Sterilizing apparatus
US2145196A (en) * 1933-11-16 1939-01-24 Hygrade Sylvania Corp Apparatus for treating foodstuffs
US3057350A (en) * 1958-06-27 1962-10-09 Baxter Don Inc Administration set
US3391951A (en) * 1966-12-07 1968-07-09 Weatherhead Co Diaphragm sealed coupling
US3626938A (en) * 1970-06-30 1971-12-14 Antonio A Versaci Hemodialysis shunt valve device with body connecting means
DE2119961C3 (en) * 1971-04-23 1982-09-30 Georg 4902 Bad Salzuflen Horstmann Device for sterilizing flowing liquids and gases
US3814680A (en) * 1971-05-06 1974-06-04 Meltzer H Process and apparatus for purification of materials
GB1428391A (en) * 1972-06-23 1976-03-17 Avon Medicals Couplings
US3780736A (en) * 1972-10-20 1973-12-25 A Chen Surgical valve assembly for urinary bladder irrigation and drainage
US3916950A (en) * 1972-11-03 1975-11-04 Stanadyne Inc Seal construction
CA1010224A (en) * 1973-02-12 1977-05-17 Neville A. Baron Asepticizing of contact lenses
DE2320990A1 (en) * 1973-04-19 1974-10-31 Hoenke Erwin DEVICE FOR STERILIZING BACTERICIDAL RADIATION OF OBJECTS
US3926556A (en) * 1973-05-30 1975-12-16 Raymond Marcel Gut Boucher Biocidal electromagnetic synergistic process
US3986508A (en) * 1973-08-22 1976-10-19 Abcor, Inc. Sterilizable, medical connector for blood processing
SE389316B (en) * 1974-03-11 1976-11-01 Ziristor Ab DEVICE FOR STERILIZING A MATERIAL PATH.
US4121107A (en) * 1974-04-10 1978-10-17 Bbc Brown, Boveri & Company Limited Apparatus for automatic low-bacteria to aseptic filling and packing of foodstuffs
US3957082A (en) * 1974-09-26 1976-05-18 Arbrook, Inc. Six-way stopcock
US4177835A (en) * 1975-01-06 1979-12-11 Paley Hyman W Plastic manifold assembly
US3955922A (en) * 1975-06-06 1976-05-11 Robert J. Patch Sterilizer for bathroom articles
US4069153A (en) * 1975-10-28 1978-01-17 American Sterilizer Company Method of destroying pyrogens
US4056116A (en) * 1976-09-08 1977-11-01 Baxter Travenol Laboratories, Inc. Valve for interconnecting sterile containers and the like
US4080965A (en) * 1976-09-30 1978-03-28 Baxter Travenol Laboratories, Inc. In-line cannula valve assembly
US4141686A (en) * 1977-03-24 1979-02-27 Lewis James H Disposable liquid sterilizer unit
DE2733344C2 (en) * 1977-07-23 1979-07-12 Alfred 7500 Karlsruhe Graentzel Apparatus for irradiating flowable media to achieve chemical reactions or reaction products
US4173234A (en) * 1977-11-25 1979-11-06 Waterous Company Transfer valve
US4291701A (en) * 1978-07-11 1981-09-29 Bell & Howell Company Pressure transducing and methods and apparatus for filling a cavity
US4242310A (en) * 1978-11-13 1980-12-30 Baxter Travenol Laboratories, Inc. Sterile connection apparatus
US4346703A (en) * 1979-01-23 1982-08-31 Baxter Travenol Laboratories, Inc. Solution container for continuous ambulatory peritoneal dialysis
CA1155725A (en) * 1979-01-23 1983-10-25 T. Michael Dennehey Solution container for continuous ambulatory peritoneal dialysis
US4219221A (en) * 1979-02-26 1980-08-26 General Electric Company Coupling for rejoining sealed tubing

Also Published As

Publication number Publication date
ZA823927B (en) 1983-04-27
US4412834A (en) 1983-11-01
IT8221579A0 (en) 1982-05-28
BR8207737A (en) 1983-05-10
JPH03184551A (en) 1991-08-12
JPH038225B2 (en) 1991-02-05
WO1982004187A1 (en) 1982-12-09
DE3278779D1 (en) 1988-08-25
DE3278100D1 (en) 1988-03-17
EP0080485A1 (en) 1983-06-08
MX152084A (en) 1985-05-28
IL65673A0 (en) 1982-08-31
EP0080485B1 (en) 1988-02-10
AU553771B2 (en) 1986-07-24
EP0175428A2 (en) 1986-03-26
IT1152221B (en) 1986-12-31
DK48483A (en) 1983-02-04
ES8306025A1 (en) 1983-05-01
DK161801C (en) 1992-02-03
DK48483D0 (en) 1983-02-04
EP0175428A3 (en) 1986-04-09
JPH0367711B2 (en) 1991-10-23
EP0080485A4 (en) 1984-04-24
IL77774A (en) 1988-11-30
ES512764A0 (en) 1983-05-01
AU8525282A (en) 1982-12-07
IL65673A (en) 1988-11-30
JPS58501158A (en) 1983-07-21
US4503333A (en) 1985-03-05
EP0175428B1 (en) 1988-07-20
DK161801B (en) 1991-08-19

Similar Documents

Publication Publication Date Title
CA1182143A (en) Antimicrobial ultraviolet irradiation of connector for continuous ambulatory peritoneal dialysis
US4475900A (en) Method of peritoneal dialysis involving ultraviolet radiation of dialysis apparatus
US4738668A (en) Conduit connectors having antiseptic application means
PT82183B (en) APPLICATION PROCESS AND LIGHTING SYSTEM CUTTED TO STERILE COLD
US4432766A (en) Conduit connectors having antiseptic application means
US4417890A (en) Antibacterial closure
US5057074A (en) Medical container replacing method
US4620845A (en) Method of peritoneal dialysis involving ultraviolet radiation of dialysis apparatus
EP0095484A1 (en) Multiple chamber system for peritoneal dialysis
US20210322753A1 (en) Transfer catheter for ultraviolet disinfection
IE54958B1 (en) Connector assembly for sterile connection of two internally sterile containers of tubings
JPS61293470A (en) Abdominal membrane dialyser and its connector
EP0084552B1 (en) Conduit connectors having antiseptic application means
WO1999022805A1 (en) Roller clamp-connector assembly
EP0113758A1 (en) A sterile fluid transfer system and an associated multiple access fluid transfer device
JPH09192216A (en) Connector with sealed-in disinfectant and connecting tube equipped therewith
JPH05269202A (en) Peritoneal dialyzer and dialyzate storage container for peritoneal dialysis
CN116077820A (en) Flow control valve of continuous ambulatory peritoneal dialysis device and use method
AU8689382A (en) Antibacterial closure

Legal Events

Date Code Title Description
MKEC Expiry (correction)
MKEX Expiry